La criptología de la enfermedad. Luis Alejandro Barrera Avellaneda

12. Kaplan F. Tay-Sachs disease carrier screening: a model for prevention of genetic disease. Genet Test. 1998;2(4):271–92.

13. Piran S, Amato D. Gaucher disease: a systematic review and meta-analysis of bone complications and their response to treatment. J Inherit Metab Dis [Internet]. 2010 Jun;33(3):271–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20336376

14. MacQueen GM, Rosebush PI, Mazurek MF. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci. 1998;10(1):10–9.

15. Ficicioglu C, An Haack K. Failure to thrive: when to suspect inborn errors of metabolism. Pediatrics [Internet]. 2009;124(3):972–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19706585

      16. El-Hattab AW, Sutton VR. Approach to Inborn Errors of Metabolism in Pediatrics. Pediatr Clin North Am. 2018.

17. Ahrens-Nicklas RC, Slap G, Ficicioglu C. Adolescent presentations of inborn errors of metabolism. Journal of Adolescent Health. 2015;56:477-82.

18. Garrod AE. A Contribution to the Study of Alkaptonuria. Med Chir Trans [Internet]. 1899;82:367–94. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2036698/

19. Garrod. The Incidence of Alkaptonuria: A study on Chemical Individuality. Lancet. 1902;II:1616–20.

20. Sewell AC, Haskins ME, Giger U. Inherited metabolic disease in companion animals: Searching for nature’s mistakes. Veterinary Journal. 2007.

      21. Rijnberk A, De Vijlder JJ, Van Dijk JE, Jorna TJ, Tegelaers WH. Congenital defect in iodothyronine synthesis. Clinical aspects of iodine metabolism in goats with congenital goitre and hypothyroidism. Br Vet J. 1977.

      22. Haskins M, Giger U, Patterson D. Animal models of lysosomal storage diseases: their development and clinical relevance. Fabry Dis Perspect from 5 years FOS. 2006.

      23. Sewell AC, Haskins ME, Giger U. Inherited metabolic disease in companion animals: Searching for nature’s mistakes. Veterinary Journal. 2007.

      24. Gurda BL, Bradbury AM, Vite CH. Canine and feline models of human genetic diseases and their contributions to advancing clinical therapies. Yale Journal of Biology and Medicine. 2017.

      25. Bath GF, Wentzel D, van Tonder EM. Cretinism in Angora goats. J S Afr Vet Assoc. 1979.

26. Ramakrishna C, Prasad MC, Ramkumar, Sharma AK. Prevalence of goitre/hypothyroidism in goats in and around Bareilly (U.P.). Indian Vet Med J. 1991.

27. Stern JR, Ochoa S. Enzymatic synthesis of acetyl phosphate. J Biol Chem [Internet]. 1951. Available from: https://pdfs.semanticscholar.org/a9d0/0256dba1b01612c028437c03588784b364e5.pdf

28. Barnett JA. A history of research on yeasts 5: The fermentation pathway. Yeast. 2003;20(6):509–43.

29. Zhang XK, Elbin CS, Chuang W-L, Cooper SK, Marashio CA, Beauregard C, et al. Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin Chem. 2008;54(10):1725–8.

30. Baussan C, Moatti N, Odievre M, Lemonnier A. Liver glycogenosis caused by a defective phosphorylase system: hemolysate analysis. Pediatrics [Internet]. 1981 Jan;67(1):107–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6787554

31. National Human Genome Research Institute. All About The Human Genome Project (HGP)–National Human Genome Research Institute (NHGRI). NIH. 2015.

32. Koeppen AH. The hereditary ataxias [Internet]. Sixth Edit. Vol. 57, Journal of Neuropathology and Experimental Neurology. Elsevier; 1998. 531–543 p. Available from: http://dx.doi.org/10.1016/B978-0-12-383834-6.00125-7

33. Opal P, Zoghbi H. Chapter 118–The Hereditary Ataxias [Internet]. Sixth Edit. Vol. 7, Emery and Rimoin’s Principles and Practice of Medical Genetics (Sixth Edition). Elsevier; 2013. 1–32 p. Available from: http://www.sciencedirect.com/science/article/pii/B9780123838346001257

34. Narravula A, Garber KB, Askree SH, Hegde M, Hall PL. Variants of uncertain significance in newborn screening disorders: implications for large-scale genomic sequencing. Genet Med. 2017 Jan 1;19(1):77–82.

35. Al Hafid N, Christodoulou J. Phenylketonuria: a review of current and future treatments. Transl Pediatr [Internet]. 2015;4(4):304–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26835392%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4728993

36. Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, et al. Phenylketonuria scientific review conference: State of the science and future research needs. Mol Genet Metab. 2014;112(2):87–122.

37. Brady RO. Enzyme replacement therapy: conception, chaos and culmination. Philos Trans R Soc B Biol Sci [Internet]. 2003 May;358(1433):915–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12803925

      38. Desnick RJ. Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis. 2004;27(3):385–410.

      39. Broomfield A, Fletcher J, Davison J, Finnegan N, Fenton M, Chikermane A, et al. Response of 33 UK patients with infantile-onset Pompe